商业 · 2004/1/161 分钟阅读
Notice of Approval of New Animal Drug Application; Ceftiofur
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is providing notice that it has approved a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co. The supplemental NADA provided revised susceptibility information for food-animal pathogens listed in the clinical microbiology section of labeling for ceftiofur hydrochloride injectable suspension.